Judith Mora
Overview
Explore the profile of Judith Mora including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
348
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rivera-Perez D, Mendez C, Diethelm-Varela B, Melo-Gonzalez F, Vazquez Y, Meng X, et al.
Front Immunol
. 2024 May;
15:1372193.
PMID: 38812507
Background: Vaccine effectiveness against SARS-CoV-2 infection has been somewhat limited due to the widespread dissemination of the Omicron variant, its subvariants, and the immune response dynamics of the naturally infected...
2.
Mendez C, Penaloza H, Schultz B, Pina-Iturbe A, Rios M, Moreno-Tapia D, et al.
EBioMedicine
. 2023 Apr;
91:104563.
PMID: 37099842
Background: The Omicron variant has challenged the control of the COVID-19 pandemic due to its immuno-evasive properties. The administration of a booster dose of a SARS-CoV-2 vaccine showed positive effects...
3.
Soto J, Melo-Gonzalez F, Gutierrez-Vera C, Schultz B, Berrios-Rojas R, Rivera-Perez D, et al.
mBio
. 2022 Nov;
13(6):e0131122.
PMID: 36383021
Multiple vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have been evaluated in clinical trials. However, trials addressing the immune response in the pediatric population are scarce. The inactivated...
4.
Galvez N, Pacheco G, Schultz B, Melo-Gonzalez F, Soto J, Duarte L, et al.
Elife
. 2022 Oct;
11.
PMID: 36226829
Background: The development of vaccines to control the coronavirus disease 2019 (COVID-19) pandemic progression is a worldwide priority. CoronaVac is an inactivated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine...
5.
Schultz B, Melo-Gonzalez F, Duarte L, Galvez N, Pacheco G, Soto J, et al.
mBio
. 2022 Aug;
13(4):e0142322.
PMID: 35946814
CoronaVac is an inactivated SARS-CoV-2 vaccine approved by the World Health Organization (WHO). Previous studies reported increased levels of neutralizing antibodies and specific T cells 2 and 4 weeks after...
6.
Schultz B, Melo-Gonzalez F, Duarte L, Galvez N, Pacheco G, Soto J, et al.
medRxiv
. 2022 Apr;
PMID: 35441179
Background: CoronaVac is an inactivated SARS-CoV-2 vaccine approved by the World Health Organization. Previous studies reported increased levels of neutralizing antibodies and specific T cells two- and four-weeks after two...
7.
Bueno S, Abarca K, Gonzalez P, Galvez N, Soto J, Duarte L, et al.
medRxiv
. 2022 Apr;
PMID: 35441164
Background: The ongoing COVID-19 pandemic has had a significant impact worldwide, with an incommensurable social and economic burden. The rapid development of safe and protective vaccines against this disease is...
8.
Melo-Gonzalez F, Soto J, Gonzalez L, Fernandez J, Duarte L, Schultz B, et al.
Front Immunol
. 2021 Dec;
12:747830.
PMID: 34858404
Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the virus responsible of the current pandemic ongoing all around the world. Since its discovery in 2019, several circulating variants have...
9.
Duarte L, Galvez N, Iturriaga C, Melo-Gonzalez F, Soto J, Schultz B, et al.
Front Immunol
. 2021 Oct;
12:742914.
PMID: 34659237
Constant efforts to prevent infections by severe acute respiratory syndrome coronavirus 2 (SARSCoV2 are actively carried out around the world. Several vaccines are currently approved for emergency use in the...
10.
Bueno S, Abarca K, Gonzalez P, Galvez N, Soto J, Duarte L, et al.
Clin Infect Dis
. 2021 Sep;
75(1):e792-e804.
PMID: 34537835
Background: The development of effective vaccines against coronavirus disease 2019 is a global priority. CoronaVac is an inactivated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine with promising safety and...